| 000 | 01707 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515154650.0 | ||
| 264 | 0 | _c20110502 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1522-9645 | ||
| 024 | 7 |
_a10.1093/eurheartj/ehn553 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHassan, Ayman K M | |
| 245 | 0 | 0 |
_aLate stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. _h[electronic resource] |
| 260 |
_bEuropean heart journal _cMay 2010 |
||
| 300 |
_a1172-80 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xtherapy |
| 650 | 0 | 4 |
_aDrug-Eluting Stents _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Occlusion, Vascular |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aProsthesis Failure _xadverse effects |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 |
_aStents _xadverse effects |
| 650 | 0 | 4 |
_aTubulin Modulators _xadministration & dosage |
| 700 | 1 | _aBergheanu, Sandrin C | |
| 700 | 1 | _aStijnen, Theo | |
| 700 | 1 | _avan der Hoeven, Bas L | |
| 700 | 1 | _aSnoep, Jaapjan D | |
| 700 | 1 | _aPlevier, Josepha W M | |
| 700 | 1 | _aSchalij, Martin J | |
| 700 | 1 | _aWouter Jukema, J | |
| 773 | 0 |
_tEuropean heart journal _gvol. 31 _gno. 10 _gp. 1172-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/eurheartj/ehn553 _zAvailable from publisher's website |
| 999 |
_c18605135 _d18605135 |
||